Ignite Creation Date:
2024-05-06 @ 9:14 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02934256
Status:
COMPLETED
Last Update Posted:
2021-09-09
First Post:
2016-10-13
Brief Title:
Icotinib Study for Patients With Neurofibromatosis Type 2 NF2 and NF2-Related Tumors
Sponsor:
Li Peng
Organization:
Beijing Tiantan Hospital
Organization Data
Organization:
Beijing Tiantan Hospital
Class:
OTHER
Study ID:
Tian-drug-neuro002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Li Peng
Lead Sponsor Class:
OTHER
Responsible Party:
Li Peng
Responsible Party Title:
principal investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Beijing Tiantan Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Betta Pharmaceuticals Co Ltd | INDUSTRY |